Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO business and affordable medicines portfolio. The company also reported margin expansion, reaffirmed its capex plans, and continued to attract higher institutional interest, boosting investor sentiment.
Indian stock markets deliver negative returns for two years, worst since 2012, ET analysis reveals
Indian stock markets have disappointed investors with negative returns over two years. The Sensex has shown its worst two-year performance since 2012. Indices have not
August 25, 2026